These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18316387)

  • 1. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.
    En J; Goto M; Nakanaga K; Higashi M; Ishii N; Saito H; Yonezawa S; Hamada H; Small PL
    Infect Immun; 2008 May; 76(5):2002-7. PubMed ID: 18316387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.
    Goto M; Nakanaga K; Aung T; Hamada T; Yamada N; Nomoto M; Kitajima S; Ishii N; Yonezawa S; Saito H
    Am J Pathol; 2006 Mar; 168(3):805-11. PubMed ID: 16507896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited repair and structural damages displayed by skeletal muscles loaded with mycolactone.
    Houngbédji GM; Côté CH; Small PL; Frenette J
    Microbes Infect; 2009 Feb; 11(2):238-44. PubMed ID: 19114122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer.
    Anand U; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev Y; Bountra C; McCarthy T; Anand P
    Mol Pain; 2016; 12():. PubMed ID: 27325560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of wild-type and mycolactone-negative mutant Mycobacterium ulcerans on skeletal muscle: IGF-1 protects against mycolactone-induced muscle catabolism.
    Dufresne SS; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R753-62. PubMed ID: 23485865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
    Sarfo FS; Phillips RO; Rangers B; Mahrous EA; Lee RE; Tarelli E; Asiedu KB; Small PL; Wansbrough-Jones MH
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e577. PubMed ID: 20052267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation.
    Houngbédji GM; Bouchard P; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R724-32. PubMed ID: 21209381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.
    Torrado E; Fraga AG; Castro AG; Stragier P; Meyers WM; Portaels F; Silva MT; Pedrosa J
    Infect Immun; 2007 Feb; 75(2):977-87. PubMed ID: 17145944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.
    Marion E; Jarry U; Cano C; Savary C; Beauvillain C; Robbe-Saule M; Preisser L; Altare F; Delneste Y; Jeannin P; Marsollier L
    J Immunol; 2016 Mar; 196(6):2690-8. PubMed ID: 26873988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.
    Converse PJ; Xing Y; Kim KH; Tyagi S; Li SY; Almeida DV; Nuermberger EL; Grosset JH; Kishi Y
    PLoS Negl Trop Dis; 2014; 8(1):e2618. PubMed ID: 24392174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
    Warryn L; Dangy JP; Gersbach P; Gehringer M; Schäfer A; Ruf MT; Ruggli N; Altmann KH; Pluschke G
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008357. PubMed ID: 32589646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation.
    Guenin-Macé L; Veyron-Churlet R; Thoulouze MI; Romet-Lemonne G; Hong H; Leadlay PF; Danckaert A; Ruf MT; Mostowy S; Zurzolo C; Bousso P; Chrétien F; Carlier MF; Demangel C
    J Clin Invest; 2013 Apr; 123(4):1501-12. PubMed ID: 23549080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E; Adusumilli S; Fraga AG; Small PL; Castro AG; Pedrosa J
    Infect Immun; 2007 Aug; 75(8):3979-88. PubMed ID: 17517872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.